Detalhe da pesquisa
1.
Efficacy and safety of tislelizumab plus lenvatinib as first-line treatment in patients with unresectable hepatocellular carcinoma: a multicenter, single-arm, phase 2 trial.
BMC Med
; 22(1): 172, 2024 Apr 23.
Artigo
em Inglês
| MEDLINE | ID: mdl-38650037
2.
EMLI-ICC: an ensemble machine learning-based integration algorithm for metastasis prediction and risk stratification in intrahepatic cholangiocarcinoma.
Brief Bioinform
; 23(6)2022 11 19.
Artigo
em Inglês
| MEDLINE | ID: mdl-36259363
3.
Interaction between baseline HBV loads and the prognosis of patients with HCC receiving anti-PD-1 in combination with antiangiogenic therapy undergoing concurrent TAF prophylaxis.
BMC Infect Dis
; 22(1): 614, 2022 Jul 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-35836207
4.
[Application of liquid biopsy in early screening and recurrence prediction of hepatocellular carcinoma].
Zhonghua Gan Zang Bing Za Zhi
; 30(8): 814-819, 2022 Aug 20.
Artigo
em Zh
| MEDLINE | ID: mdl-36207938
5.
FOXC2 is a prognostic biomarker and contributes to the growth and invasion of human hepatocellular carcinoma.
Cancer Cell Int
; 20: 196, 2020.
Artigo
em Inglês
| MEDLINE | ID: mdl-32508532
6.
Withdrawn: Effectiveness and safety of toripalimab, camrelizumab and sintilimab in a real-world cohort of hepatitis B virus associated hepatocellular carcinoma patients.
Br J Clin Pharmacol
; 86(10): 2102, 2020 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-32627214
7.
MiR-661 promotes tumor invasion and metastasis by directly inhibiting RB1 in non small cell lung cancer.
Mol Cancer
; 16(1): 122, 2017 07 17.
Artigo
em Inglês
| MEDLINE | ID: mdl-28716024
8.
Transarterial chemoembolization with/without immune checkpoint inhibitors plus tyrosine kinase inhibitors for unresectable hepatocellular carcinoma: a single center, propensity score matching real-world study.
Discov Oncol
; 15(1): 68, 2024 Mar 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-38460053
9.
A novel engineered IL-21 receptor arms T-cell receptor-engineered T cells (TCR-T cells) against hepatocellular carcinoma.
Signal Transduct Target Ther
; 9(1): 101, 2024 Apr 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-38643203
10.
Spleen-dedicated stiffness measurement performed well to rule out high-risk varices in HBV-related hepatocellular carcinoma: Screening for high-risk varices in HCC.
Aliment Pharmacol Ther
; 59(5): 680-691, 2024 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-38155565
11.
Arterial chemotherapy for hepatocellular carcinoma in China: consensus recommendations.
Hepatol Int
; 18(1): 4-31, 2024 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-37864725
12.
Immune checkpoint inhibitors and anti-vascular endothelial growth factor antibody/tyrosine kinase inhibitors with or without transarterial chemoembolization as first-line treatment for advanced hepatocellular carcinoma (CHANCE2201): a target trial emulation study.
EClinicalMedicine
; 72: 102622, 2024 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-38745965
13.
Promising biomarkers for predicting the outcomes of patients with KRAS wild-type metastatic colorectal cancer treated with anti-epidermal growth factor receptor monoclonal antibodies: a systematic review with meta-analysis.
Int J Cancer
; 133(8): 1914-25, 2013 Oct 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-23494461
14.
KRAS p.G13D mutation and codon 12 mutations are not created equal in predicting clinical outcomes of cetuximab in metastatic colorectal cancer: a systematic review and meta-analysis.
Cancer
; 119(4): 714-21, 2013 Feb 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-22972628
15.
Tyrosine kinase inhibitors, immune checkpoint inhibitors combined with hepatic arterial infusion of oxaliplatin and raltitrexed versus oxaliplatin, 5-fluorouracil and leucovorin for intermediate and advanced hepatocellular carcinoma: A retrospective study.
Int Immunopharmacol
; 125(Pt A): 111019, 2023 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-37879230
16.
Proteomic and single-cell landscape reveals novel pathogenic mechanisms of HBV-infected intrahepatic cholangiocarcinoma.
iScience
; 26(2): 106003, 2023 Feb 17.
Artigo
em Inglês
| MEDLINE | ID: mdl-36852159
17.
Characterization of somatic mutations and pathway alterations during hepatocellular carcinoma vascular invasion using next-generation sequencing.
J Gastrointest Oncol
; 13(4): 1864-1874, 2022 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-36092348
18.
Cross talk between acetylation and methylation regulators reveals histone modifier expression patterns posing prognostic and therapeutic implications on patients with colon cancer.
Clin Epigenetics
; 14(1): 70, 2022 05 23.
Artigo
em Inglês
| MEDLINE | ID: mdl-35606881
19.
Hepatic Tumor Stiffness Measured by Shear Wave Elastography Is Prognostic for HCC Progression Following Treatment With Anti-PD-1 Antibodies Plus Lenvatinib: A Retrospective Analysis of Two Independent Cohorts.
Front Immunol
; 13: 868809, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-35757765
20.
Lenvatinib Plus Camrelizumab vs. Lenvatinib Monotherapy as First-Line Treatment for Unresectable Hepatocellular Carcinoma: A Multicenter Retrospective Cohort Study.
Front Oncol
; 12: 809709, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-35280760